End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
70.98 CNY | +1.55% | -0.81% | -13.86% |
May. 15 | Sino Biological,Inc. Approves Cash Dividend for the Year 2023 | CI |
Apr. 28 | Sino Biological,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 626M 86.45M | Sales 2025 * | 736M 102M | Capitalization | 9.07B 1.25B |
---|---|---|---|---|---|
Net income 2024 * | 263M 36.32M | Net income 2025 * | 322M 44.47M | EV / Sales 2024 * | 14.5 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 12.3 x |
P/E ratio 2024 * |
34.9
x | P/E ratio 2025 * |
28.5
x | Employees | 953 |
Yield 2024 * |
1.99% | Yield 2025 * |
-
| Free-Float | 29.32% |
1 day | +1.55% | ||
1 week | -0.81% | ||
1 month | +0.67% | ||
3 months | -1.83% | ||
6 months | -19.60% | ||
Current year | -13.86% |
Managers | Title | Age | Since |
---|---|---|---|
Jie Zhang
CEO | Chief Executive Officer | 51 | 16-12-31 |
Jing Wang
CHM | Chairman | 39 | 16-12-31 |
Tao Feng
DFI | Director of Finance/CFO | 43 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yong You
BRD | Director/Board Member | 51 | 23-04-11 |
Shi Zhou Yin
BRD | Director/Board Member | 51 | 20-03-25 |
Liang Zhi Xie
CHM | Chairman | 58 | 16-12-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 70.98 | +1.55% | 558,050 |
24-05-30 | 69.9 | -0.54% | 362,512 |
24-05-29 | 70.28 | -0.61% | 347,990 |
24-05-28 | 70.71 | -0.66% | 353,913 |
24-05-27 | 71.18 | -0.53% | 534,640 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.86% | 1.25B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- 301047 Stock